Loading patent…
OwnerPal Aukrust, Stig Froland +10inventors
InventorsPal Aukrust, Stig Froland, Svein Simonsen, Halfdan Aass, Jan Fjeld, Arne Andreassen, Halfdan Ihlen, John Kjekshus, Sigurd Nitter-Hauge, Thor Ueland, Lars Gullestad, Egil Lien
Estimating the term…
The present invention relates to the use of an immunomodulating agent, in particular intravenous immunoglobulin (IVIG), in the manufacture of a medicament for use in the treatment of non-viral or non-autoimmune induced heart disorders or non-viral or non-autoimmune associated phases of heart disorders or the symptoms associated therewith. Particular heart disorders to be treated are selected from the group comprising chronic CHF, chronic (stable) angina pectoris and acute coronary syndromes. Pharmaceutical compositions for use in the treatment of such disorders comprising immunomodulating agents are also provided.
Use of intravenous immunoglobulin (IVIG) in the manufacture of a medicament for use in the treatment of non-viral or non-autoimmune induced heart disorders or non-viral or non-autoimmune associated phases of heart disorders, wherein said heart disorder is an ischaemic heart disease or a chronic non-ischaemic cardiomyopathy.
Use of intravenous immunoglobulin (IVIG) in the manufacture of a medicament for use in the treatment of a disease which involves an imbalance in the chemokine network.
Use of an agent which increases the levels or activity of one or more anti-inflammatory mediators in the manufacture of a medicament for use in the treatment of non-viral or non-autoimmune induced heart disorders or non-viral or non-autoimmune associated phases of heart disorders, wherein said heart disorder is an ischaemic heart disease or a chronic non-ischaemic cardiomyopathy.
Dependencies are inferred from the claim text.